Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

被引:415
|
作者
Videla, LA
Rodrigo, R
Orellana, M
Fernandez, V
Tapia, G
Quiñones, L
Varela, N
Contreras, J
Lazarte, R
Csendes, A
Rojas, J
Maluenda, F
Burdiles, P
Diaz, JC
Smok, G
Thielemann, L
Poniachik, J
机构
[1] Univ Chile, Mol & Clin Pharmacol Program, Inst Biomed Sci, Fac Med, Santiago 7, Chile
[2] Univ Chile, Clin Hosp, Dept Med, Santiago 7, Chile
[3] Univ Chile, Clin Hosp, Dept Surg, Santiago 7, Chile
[4] Univ Chile, Clin Hosp, Dept Pathol Anat, Santiago 7, Chile
[5] Univ Chile, Fac Med, Pathophysiol Program, Inst Biomed Sci, Santiago 7, Chile
关键词
non-alcoholic fatty liver disease; oxidative stress; steatohepatitis; steatosis;
D O I
10.1042/CS20030285
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Oxidative stress is implicated in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). In the present study, hepatic and plasma oxidative stress-related parameters were measured and correlated with clinical and histological findings in 31 NAFLD patients showing increased body mass index. Liver protein carbonyl content was enhanced by 403 % in patients with steatosis (n = 15) compared with control values (n = 12), whereas glutathione content, superoxide dismutase (SOD) activity and the ferric reducing ability of plasma (FRAP) were decreased by 57 %, 48 % and 2 1 % (P < 0.05) respectively. No changes in microsomal p-nitrophenol hydroxylation and the total content of cytochrome P450 (CYP) or CYP2EI were observed. Patients with steatohepatitis (n = 16) exhibited protein carbonyl content comparable with that of controls, whereas glutathione content, SOD and catalase activities were decreased by 27%, 64% and 48% (P<0.05). In addition, FRAP values in patients with steatohepatitis were reduced by 33 % and 15 % (P < 0.05) when compared with controls and patients with steatosis respectively, whereas p-nitrophenol hydroxylation (52 %) and CYP2EI content (142 %) were significantly increased (P < 0.05) compared with controls. It is concluded that oxidative stress is developed in the liver of NAFLD patients with steatosis and is exacerbated further in patients with steatohepatitis, which is associated with CYP2EI induction. Substantial protein oxidation is followed by proteolysis of the modified proteins, which may explain the co-existence of a diminished antioxidant capacity and protein oxidation in the liver of patients with steatohepatitis.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [42] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [43] Moexipril in patients with non-alcoholic fatty liver disease
    Silveira, Marina G.
    Talwalkar, Jay A.
    Lindor, Keith D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S234 - S234
  • [44] Predicting severe liver disease in patients with non-alcoholic fatty liver
    Kahl, S.
    DIABETOLOGE, 2017, 13 (07): : 514 - 516
  • [45] Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
    Cainelli, Francesca
    Thao, Titya
    Pung, Carolyne
    Vento, Sandro
    FRONTIERS IN MEDICINE, 2020, 7
  • [46] EXPRESSION OF RESISTIN IN THE LIVER OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Gierej, Piotr
    Gierej, Beata
    Kalinowski, Piotr
    Wroblewski, Tadeusz
    Paluszkiewicz, Rafal
    Kobryn, Konrad
    Ziarkiewicz-Wroblewska, Bogna
    POLISH JOURNAL OF PATHOLOGY, 2017, 68 (03) : 225 - 233
  • [47] Orthotopic Liver Transplantation in Non-Alcoholic Fatty Liver Disease Patients
    Burra, Patrizia
    Germani, Giacomo
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (03) : 210 - 216
  • [48] Non-alcoholic fatty liver disease in patients with migraine
    Asuman Celikbilek
    Mehmet Celikbilek
    Aylin Okur
    Serkan Dogan
    Elif Borekci
    Mustafa Kozan
    Sebnem Gursoy
    Neurological Sciences, 2014, 35 : 1573 - 1578
  • [49] Non-Alcoholic Fatty Liver Disease in Non-Liver Transplant Patients
    Claudio, R.
    Conceicao, C.
    Robichaux, K.
    Kumar, A.
    Buggs, J.
    Kemmer, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 753 - 753
  • [50] Statins for Patients With Non-Alcoholic Fatty Liver Disease
    AlGhamdi, Talal Shakas
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 10 (06) : 162 - 166